Methods for studying nucleic acid/drug interactions / (Record no. 48709)

MARC details
000 -LEADER
fixed length control field 02078cmm a2200265 a 4500
001 - CONTROL NUMBER
control field 46699
003 - CONTROL NUMBER IDENTIFIER
control field IN-BdCUP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230426175552.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230426s2023 u eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781439839744
040 ## - CATALOGING SOURCE
Language of cataloging eng
Transcribing agency IN-BdCUP
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.704
Item number M592
245 #0 - TITLE STATEMENT
Title Methods for studying nucleic acid/drug interactions /
Statement of responsibility, etc. [edited by] Meni Wanunu, Yitzhak Tor
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Boca Raton :
Name of publisher, distributor, etc. CRC Press,
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xviii, 373 pages)
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note section 1. Classical techniques -- section 2. Emerging techniques
520 ## - SUMMARY, ETC.
Summary, etc. Since most therapeutic efforts have been predominantly focused on pharmaceuticals that target proteins, there is an unmet need to develop drugs that intercept cellular pathways that critically involve nucleic acids. Progress in the discovery of nucleic acid binding drugs naturally relies on the availability of analytical methods that assess the efficacy and nature of interactions between nucleic acids and their putative ligands. This progress can benefit tremendously from new methods that probe nucleic acid/ligand interactions both rapidly and quantitatively. A variety of novel methods for these studies have emerged in recent years, and Methods for Studying DNA/Drug Interactions highlights new and non-conventional methods for exploring nucleic acid/ligand interactions. Designed to present drug-developing companies with a survey of possible future techniques, the book compares their drawbacks and advantages with respect to commonly used tools. Perhaps more importantly, this book was written to inspire young scientists to continue to advance these methods into fruition, especially in light of current capabilities for assay miniaturization and enhanced sensitivity using microfluidics and nanomaterials--Provided by publisher
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nucleic Acids
Topical term or geographic name entry element Drug interactions
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Wanunu, Meni
Relator term Editor
Personal name Tor, Yitzhak
856 ## - ELECTRONIC LOCATION AND ACCESS
Materials specified Electronic Book Resource
Uniform Resource Identifier <a href="https://www.taylorfrancis.com/books/9781439839744">https://www.taylorfrancis.com/books/9781439839744</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type E-Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Total checkouts Full call number Barcode Date last seen Uniform resource identifier Bill Date Koha item type
    Dewey Decimal Classification     Ranganathan Library Ranganathan Library 07/04/2022 Taylor & Francis   615.704 M592 E01303 26/04/2023 https://www.taylorfrancis.com/books/9781439839744 07/04/2022 E-Book
This system is made operational by the in-house staff of the CUP Library.